isomethyleugenol has been researched along with Psoriasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pink, AE; White, IR; White, JM | 1 |
| Abad-Santos, F; Chicharro, P; Cibrian, D; Dauden, E; de la Fuente, H; Fernández-Messina, L; Jiménez-Fernández, M; Llamas-Velasco, M; Martínez-Fleta, P; Ovejero-Benito, MC; Rodríguez-Jiménez, P; Sánchez-García, I; Sánchez-Madrid, F; Vara, A; Vera-Tomé, P | 1 |
| Gao, M; Si, X | 1 |
| Abad-Santos, F; Cabaleiro, T; Daudén, E; Llamas-Velasco, M; Martín-Vilchez, S; Muñoz-Aceituno, E; Ochoa, D; Ovejero-Benito, MC; Reolid, A; Román, M; Saiz-Rodríguez, M; Sánchez-Jiménez, P | 1 |
| Mallet, AI; Woollard, PM | 1 |
| Etter, JC; Jenner, P; Pannatier, A; Testa, B | 1 |
1 review(s) available for isomethyleugenol and Psoriasis
| Article | Year |
|---|---|
The skin as a drug-metabolizing organ.
Topics: Cytochrome P-450 Enzyme System; Glucuronates; Humans; Hydrolysis; Methylation; Mixed Function Oxygenases; Oxidation-Reduction; Oxidoreductases; Pharmaceutical Preparations; Psoriasis; Skin; Sulfates | 1978 |
5 other study(ies) available for isomethyleugenol and Psoriasis
| Article | Year |
|---|---|
A call for full ingredient labelling and uniform nomenclature on medicaments.
Topics: Aged; Anisoles; Consumer Product Safety; Dermatitis, Allergic Contact; Female; Humans; Product Labeling; Psoriasis; Scalp Dermatoses | 2009 |
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Differentiation; Apoptosis; Cell Cycle Proteins; Dendritic Cells; Epigenesis, Genetic; Female; Humans; Inflammation; Keratinocytes; Male; Methylation; Middle Aged; Psoriasis; Skin; T-Lymphocytes; Ubiquitin Thiolesterase | 2021 |
Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo.
Topics: Animals; Cell Proliferation; Cytoskeleton; Down-Regulation; Female; Gene Expression; HEK293 Cells; Humans; Imiquimod; Immunosuppressive Agents; Keratinocytes; Male; MAP Kinase Signaling System; Methylation; Mice; Psoriasis; S Phase Cell Cycle Checkpoints; Sirolimus; TOR Serine-Threonine Kinases; Tropomyosin | 2018 |
Histone modifications associated with biological drug response in moderate-to-severe psoriasis.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Biomarkers; Dermatologic Agents; Epigenesis, Genetic; Female; Histones; Humans; Leukocytes, Mononuclear; Longitudinal Studies; Male; Methylation; Middle Aged; Psoriasis; Ustekinumab; Young Adult | 2018 |
Lipoxygenase products. A novel gas chromatographic-mass spectrometric assay for monohydroxy fatty acids.
Topics: Chromatography, Gas; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Fatty Acids; Gas Chromatography-Mass Spectrometry; Humans; Lipoxygenase; Methylation; Oxidation-Reduction; Psoriasis; Scintillation Counting; Skin | 1984 |